Stock Screener

Show:

Sort

Country

Sector

Risk rating

1

2

3

4

5

6

7

Risk factors

Default risk

1

2

3

4

5

6

7

Volatility

1

2

3

4

5

6

7

Stress test

1

2

3

4

5

6

7

Selling difficulty

1

2

3

4

5

6

7

Country risks

1

2

3

4

5

6

7

Other risks

1

2

3

4

5

6

7

Profitability factors

Valuation

1

2

3

4

5

6

7

Analyst view

1

2

3

4

5

6

7

Performance

1

2

3

4

5

6

7

Profitability

1

2

3

4

5

6

7

Growth

1

2

3

4

5

6

7

Dividends

1

2

3

4

5

6

7

Results: 44

Roche Holding AG

Novartis AG

Lonza Group AG

CRISPR Therapeutics AG

GALDERMA GROUP N

Alcon Inc.

BeOne Medicines AG

Sandoz Group AG

Straumann Holding AG

Sonova Holding AG

MoonLake Immunotherapeutics

NovoCure Limited

Galenica AG

Siegfried Holding AG

Tecan Group AG

Oculis Holding AG

Idorsia Ltd

Ypsomed Holding AG

Kuros Biosciences AG

Pharvaris N.V.

Medacta Group SA

ADC Therapeutics SA

Basilea Pharmaceutica AG

Bachem Holding AG

PolyPeptide Group AG

SKAN Group AG

Santhera Pharmaceuticals Holding AG

DocMorris AG

AC Immune SA

SOPHiA GENETICS S.A.

Medartis Holding AG

COLTENE Holding AG

Metall Zug AG

DocMorris AG

Molecular Partners AG

Relief Therapeutics Holding SA

IVF Hartmann Holding AG

Aevis Victoria SA

Addex Therapeutics Ltd

EvoNext Holdings SA

Mymetics Corporation

SES Solar Inc.

Bionovate Technologies Corp

NewcelX Ltd.

Guru Portfolios

Track the investments of top funds and market legends